Investing.com - Enfusion reported on Thursday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Enfusion announced earnings per share of $0.02 on revenue of $39.2M. Analysts polled by Investing.com anticipated EPS of $0.02 on revenue of $38.59M.
Enfusion shares are down 28.35% from the beginning of the year, still down 43.77% from its 52 week high of $23.21 set on November 15, 2021.
Enfusion follows other major Information Technology sector earnings this month
Enfusion's report follows an earnings beat by Apple on October 27, who reported EPS of $1.29 on revenue of $90.1B, compared to forecasts EPS of $1.26 on revenue of $88.76B.
Microsoft had beat expectations on October 25 with first quarter EPS of $2.35 on revenue of $50.1B, compared to forecast for EPS of $2.32 on revenue of $49.86B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar